Protaryx Medical announced that it received FDA 510(k) clearance for its proprietary Transseptal Puncture Device.

Read ahead to know about what a cardiac shunt is its types symptoms causes and treatment options An expert shares when to ...

The ACC issued new guidance for managing common pediatric left-to-right shunts, including ASD, VSD, and PDA, in the ...

Device-based left atrial appendage (LAA) closure was comparable to non-vitamin K antagonist oral anticoagulant (NOAC) therapy in reducing the combined rate of death from cardiovascular causes, stroke, ...

MARLBOROUGH, Mass. and NEW ORLEANS, March 28, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the CHAMPION-AF global clinical trial met all primary and secondary ...

Data highlights the WATCHMAN FLX device provided statistically superior protection from bleeding, demonstrated similar efficacy compared to blood thinners in patients with non-valvular atrial ...

For patients with atrial fibrillation, the use of oral anticoagulant therapy to prevent stroke is limited by the risk of bleeding. Left atrial appendage closure is considered for patients who are ...

Please provide your email address to receive an email when new articles are posted on . In patients with atrial fibrillation, left atrial appendage closure was superior to anticoagulation for bleeding ...

For patients with non-valvular atrial fibrillation (AFib) who had no contraindications to taking oral anticoagulants, the use of a device to close off the left atrial appendage in the heart—a small ...

EL CERRITO — A stretch of San Pablo Avenue in El Cerrito was closed for about an hour Monday after a suspicious device was discovered on a sidewalk, police said. Related Articles Suspected driver in ...

Three Successful First-in-Human Cases Completed in El Salvador Company to Exhibit at SAGES 2026 Annual Meeting in Tampa MISGAV, Israel, March 16, 2026 /PRNewswire/ -- Seger Surgical Solutions Ltd.

BOSTON, March 4, 2026 /PRNewswire/ -- Intrinsic Therapeutics, Inc. has introduced the Barricaid ® Narrow Anchor, the next generation of its FDA PMA-approved Barricaid ® Bone-Anchored Annular Closure ...